In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Boston Scientific acquires Cardiac Pathways

Executive Summary

Boston Scientific has acquired heart device maker Cardiac Pathways Corp. (devices to monitor and treat tachyarrhythmias) for about $115mm ($5.26 per share, a 40% premium to its recent trading average of $3.75) through a cash tender offer.
Deal Industry
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Radiofrequency Devices
    • Therapeutic Equipment & Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Contract
    • Payment Includes Cash
    • Full Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register